Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00240513Phase 4Terminated
Phase 4, randomised, single-blind trial of tretinoin in acne vulgaris (2 arms), sponsored by DermResearch. Primary endpoint: Long-term efficacy at 4 years. Started Aug 2004; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00240513.